TBIO-20. CLINICAL TUMOR WHOLE EXOME SEQUENCING FOR PEDIATRIC NEURO-ONCOLOGY PATIENTS – RESULTS FROM THE BAYLOR ADVANCING SEQUENCING IN CHILDHOOD CANCER CARE (BASIC3) CLINICAL SEQUENCING STUDY

Ítems similars

• GENE-16. EVALUATING THE UTILITY OF INTEGRATED CLINICAL SEQUENCING FOR CHILDHOOD NEURO-ONCOLOGY PATIENTS: THE TEXAS KIDSCANSEQ STUDY
  per: Mangum, Ross, et al.
  Publicat: (2019)
• ASSESSING THE UTILITY OF CLINICAL TUMOR SEQUENCING IN THE PEDIATRIC NEURO-ONCOLOGY CLINIC
  per: Parsons, D. Williams, et al.
  Publicat: (2014)
• GENE-09. MUTATION SIGNATURE ANALYSIS IN AN ULTRAHYPERMUTATED MEDULLOBLASTOMA PREDICTS UNDERLYING GERMLINE POLYMERASE PROOFREADING DEFICIENCY IN A CHILD WITH CLINICAL FEATURES OF CONSTITUTIONAL MISMATCH REPAIR DEFICIENCY SYNDROME
  per: Lindsay, Holly, et al.
  Publicat: (2019)
• GE-06 IDENTIFICATION OF TARGETABLE MUTATIONS IN RARE PEDIATRIC BRAIN TUMORS BY CLINICAL WHOLE EXOME SEQUENCING
  per: Lin, Frank Y., et al.
  Publicat: (2015)
• Integrated tumor and germline whole-exome sequencing identifies mutations in MAPK and PI3K pathway genes in an adolescent with rosette-forming glioneuronal tumor of the fourth ventricle
  per: Lin, Frank Y., et al.
  Publicat: (2016)